AVEO Pharmaceuticals Total Shareholders Equity 2011-2026 | AVEO

Annual Total Shareholders Equity AVEO Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.9 M	35.3 M	14.8 M	-27.2 M	-40.8 M	-1.92 M	17.2 M	20.6 M	69.9 M	119 M	224 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
224 M	-40.8 M	43.3 M

Quarterly Total Shareholders Equity AVEO Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	28.8 M	30.6 M	36.9 M	45.9 M	51.2 M	60.2 M	72.6 M	35.3 M	35.3 M	35.3 M	35.3 M	14.8 M	14.8 M	14.8 M	14.8 M	-27.2 M	-27.2 M	-27.2 M	-27.2 M	-40.8 M	-40.8 M	-40.8 M	-40.8 M	-1.92 M	-1.92 M	-1.92 M	-1.92 M	17.2 M	17.2 M	17.2 M	17.2 M	20.6 M	20.6 M	20.6 M	20.6 M	69.9 M	69.9 M	69.9 M	69.9 M	119 M	119 M	119 M	119 M	224 M	224 M	224 M	224 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
224 M	-40.8 M	43.6 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	382 M	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	176 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	54.4 M	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	884 M	$ 221.14	2.6 %	$ 5 B	Danmark
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Processa Pharmaceuticals PCSA	5.58 M	$ 2.37	1.72 %	$ 3.1 M	USA
Amphastar Pharmaceuticals AMPH	789 M	$ 19.6	1.92 %	$ 916 M	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	5.47 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	78.4 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	66.6 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	195 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	57.1 M	-	-3.03 %	$ 260 M	USA
Phathom Pharmaceuticals PHAT	-438 M	$ 10.35	2.88 %	$ 755 M	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-16.8 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Phio Pharmaceuticals Corp. PHIO	20.1 M	$ 1.27	4.09 %	$ 7.6 M	USA
Avenue Therapeutics ATXI	2.8 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	427 M	$ 1.35	1.89 %	$ 344 M	Britain
Corbus Pharmaceuticals Holdings CRBP	148 M	$ 8.23	0.61 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	1.92 B	$ 47.4	2.09 %	$ 4.26 B	Schweiz
Cyclacel Pharmaceuticals CYCC	-2.17 M	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	286 M	-	-	$ 3.74 B	USA
Pliant Therapeutics PLRX	181 M	$ 1.32	3.13 %	$ 81 M	USA
PMV Pharmaceuticals PMVP	105 M	$ 1.39	-0.36 %	$ 73 M	USA
Dynavax Technologies Corporation DVAX	597 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	188 M	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	-21.3 M	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	2.53 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Prelude Therapeutics Incorporated PRLD	68.6 M	$ 3.26	4.49 %	$ 251 M	USA
ProQR Therapeutics N.V. PRQR	113 M	$ 1.53	2.35 %	$ 99.5 M	Niderland
Arbutus Biopharma Corporation ABUS	76.6 M	$ 4.51	4.76 %	$ 864 M	Canada
Homology Medicines FIXX	42 M	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA